位置:成果数据库 > 期刊 > 期刊详情页
小剂量辛伐他汀对稳定期慢性阻塞性肺疾病患者生活质量的影响
  • ISSN号:1674-4985
  • 期刊名称:《中国医学创新》
  • 时间:0
  • 分类:R563.05[医药卫生—呼吸系统;医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]广东省深圳市光明新区光明医院,广东深圳518087, [2]广东省深圳市宝安区人民医院
  • 相关基金:2012年深圳市宝安区科学技术局立项(2012019)
中文摘要:

目的:观察小剂量辛伐他汀(10 mg/次,每晚1次)为期1年的治疗对中度稳定期慢性阻塞性肺疾病(COPD)患者生活质量的影响。方法:选取符合纳入标准的60例中度稳定期慢性阻塞性肺疾病患者,按照随机数字表法将其分为试验组和对照组各30例,对照组采取常规治疗1年,试验组在常规治疗的基础上加用辛伐他汀10 mg/次,每晚1次,口服1年,记录并比较1年前后两组患者COPD评估测试(CAT)评分。结果:两组患者治疗前CAT评分比较差异无统计学意义(P〉0.05),治疗1年后两组CAT评分均明显优于治疗前,且试验组CAT评分明显优于对照组,比较差异均有统计学意义(P〈0.05)。结论:小剂量辛伐他汀可以改善COPD患者生活质量,值得在临床上推广。

英文摘要:

Objective:To observe the low-dose simvastatin(10 mg/times,once a night) a period of one year of treatment for moderate stable chronic obstructive pulmonary disease(COPD) patients quality of life impact.Method:60 patients with moderate stable chronic obstructive pulmonary disease were randomly divided into the experimental group and the control group,30 cases in each group.The control group was treated with conventional therapy for one year,the experimental group was treated with oral simvastatin 10 mg/times,once a night for 1 year on the basis of conventional therapy.COPD assessment test(CAT) score of the two groups before and after one year were recorded and compared.Result:Before treatment,the CAT scores had no significant differences between the two groups(P〉0.05),after one year of treatment,CAT scores of the two groups were significantly better than before treatment,and CAT of the experimental group was significantly better than the control group,the differences were statistically significant(P〈0.05).Conclusion:Low-dose simvastatin can improve the quality of life in patients with COPD,it is worth promoting in clinical practice.

同期刊论文项目
期刊论文 68
同项目期刊论文
期刊信息
  • 《中国医学创新》
  • 主管单位:国家卫生和计划生育委员会
  • 主办单位:中国保健协会
  • 主编:
  • 地址:北京市丰台区菜户营58号财富西环15A05室
  • 邮编:100054
  • 邮箱:zgyxcx01@163.com
  • 电话:010-63357546 63357548
  • 国际标准刊号:ISSN:1674-4985
  • 国内统一刊号:ISSN:11-5784/R
  • 邮发代号:82-189
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版)
  • 被引量:56531